3/10
08:37 am
rsls
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology [Yahoo! Finance]
High
Report
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology [Yahoo! Finance]
3/10
08:31 am
rsls
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
High
Report
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
2/25
08:31 am
rsls
ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX
High
Report
ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX
2/16
12:28 am
rsls
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering [Yahoo! Finance]
High
Report
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering [Yahoo! Finance]
2/15
11:17 pm
rsls
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering
High
Report
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering
2/3
09:43 am
rsls
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology [Yahoo! Finance]
Medium
Report
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology [Yahoo! Finance]
2/3
08:50 am
rsls
ReShape Lifesciences receives international patent in Israel for its proprietary diabetes neuromodulation technology; shares rise [Seeking Alpha]
Medium
Report
ReShape Lifesciences receives international patent in Israel for its proprietary diabetes neuromodulation technology; shares rise [Seeking Alpha]
2/3
08:31 am
rsls
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
High
Report
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
1/23
06:00 pm
rsls
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - RSLS, TURN, RDW, NEUE
Low
Report
$TOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger - RSLS, TURN, RDW, NEUE
1/13
08:31 am
rsls
ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
Medium
Report
ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
12/20
07:22 am
rsls
ReShape Lifesciences files to sell up to 2.11M shares for holder [Seeking Alpha]
Medium
Report
ReShape Lifesciences files to sell up to 2.11M shares for holder [Seeking Alpha]